Presentation TCT 2016 PSP: A Synthesis of Technique Imperatives for Absorb Implantation Presenter: Stephen G. Ellis, Patrick W. Serruys, David G. Rizik November 01, 2016
Presentation TCT 2016 Industry Perspectives: Balancing Innovation and Robust Clinical Evidence Generation With Declining DES Use and Reimbursement Presenter: Michael C. John, Gregg W. Stone, Jason R. Weidman November 01, 2016
Presentation TCT 2016 Bare Metal and 1st Generation Drug-Eluting Stents: Devices, Indications, and Outcomes Presenter: Dmitriy N. Feldman, Emmanouil S. Brilakis November 01, 2016
Presentation TCT 2016 Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch Presenter: Stephen G. Ellis, Patrick W. Serruys November 01, 2016
Presentation TCT 2016 Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution Presenter: Philip M. Urban, Stephen G. Worthley, Christian M. Spaulding November 01, 2016
Presentation TCT 2016 Bioresorbable Scaffolds - Lessons Learned From the ABSORB Odyssey: Industry Perspectives Presenter: Michael C. John, Gregg W. Stone, Chuck Simonton November 01, 2016
Presentation TCT 2016 Patient and Lesion Selection for BRS: What Is Optimal and What Should Be Avoided? Presenter: Stephen G. Ellis, Patrick W. Serruys, Christoph K. Naber November 01, 2016
Presentation TCT 2016 FDA Perspectives on Short DAPT IDE Trials Presenter: Michael C. John, Gregg W. Stone, Andrew Farb November 01, 2016
Presentation TCT 2016 BRS Benchtop Findings: Implications for Implantation Techniques Presenter: Stephen G. Ellis, Patrick W. Serruys, Nicolas Foin November 01, 2016
Presentation TCT 2016 Impact of Different PLLA Polymers and BRS Construction on Implant Technique: From Absorb to DESolve to Fantom to Manli and More Presenter: Stephen G. Ellis, Patrick W. Serruys, Alexandre Abizaid November 01, 2016
Presentation TCT 2016 Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS Presenter: Philip M. Urban, Stephen G. Worthley, Sigmund Silber November 01, 2016
Presentation TCT 2016 FDA Regulatory Considerations for Novel and Not-So-Novel New Metallic DES and Bioresorbable Scaffolds Presenter: Michael C. John, Gregg W. Stone, P.F. Adrian Magee November 01, 2016
Presentation TCT 2016 Novel DCB Coatings and Alternative Drugs: Are We Reaching the End of the Road? Presenter: Fernando Alfonso, Juan F. Granada November 01, 2016
Presentation TCT 2016 Methods and Technologies to Improve DCB Outcomes: Does the Data Support Their Use? Presenter: Fernando Alfonso, Juan F. Granada, Azeem Latib November 01, 2016
Presentation TCT 2016 Return Fire: The Contrarian View - Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI! Presenter: Sanjay Kaul, Jeffrey J. Popma, Michael Haude November 01, 2016
News Conference News TCT 2016 ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events Michael O'Riordan November 01, 2016
Presentation TCT 2016 DCB for De Novo Lesions: Clinical Applications and Technical Pitfalls Presenter: Fernando Alfonso, Juan F. Granada, Bernardo Cortese November 01, 2016
Presentation TCT 2016 Opening Salvo: I Don't Believe Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI! Presenter: Sanjay Kaul, Jeffrey J. Popma, Salvatore Cassese November 01, 2016
Presentation TCT 2016 DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes! The Data is Solid and DCB Should be the Treatment of Choice! Presenter: Fernando Alfonso, Juan F. Granada, Bruno Scheller November 01, 2016
Presentation TCT 2016 PLATINUM DIVERSITY: Outcomes From a Large-Scale, Prospective Registry of Coronary Artery Stent Implantation in Women and Minorities Presenter: Howard C. Herrmann, Robert J. de Winter, Wayne B. Batchelor November 01, 2016